📈 Markets & Finance
Live
Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case
Written by Prosper Junior Bakiny for The Motley Fool -> Viking Therapeutics has a promising pipeline candidate in late-stage studies. Positive results from ongoing phase 3 trials could send the stoc
Nasdaq News — 28 July 2026
Text:
22
0
0
Viking Therapeutics has a promising pipeline candidate in late-stage studies.
Positive results from ongoing phase 3 trials could send the stock soari
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
Higher Open Called For Indonesia Stock Market
📈 Markets & Finance
Investors withdraw $475 million from American Bitcoin ETFs, market confidence falters.
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
